Attorney Articles

FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing

April 3, 2019 - Cannabis Business Executive

Ian Stewart (Partner-Los Angeles) and Neil Willner (Associate-White Plains) took a hard look at the U.S. Food and Drug Administration’s (FDA’s) sweeping press release issued on April 2, 2019, by outgoing Commissioner Scott Gottlieb. Covering new steps to advance the FDA’s continued evaluation of potential regulatory pathways for CBD products, the new guidance outlined what the FDA has in store for the industry over the next several months. 

Read the Article.